Table 2.
Distribution of study isolates according to clinical sources
| Isolate | Clinical source | Number of species | ||||||
|---|---|---|---|---|---|---|---|---|
| Urine | Blood | Sputum | CSF | HVS | Othera | Total | % | |
| Citrobacter spp. | 2 | 1 | 6 | 0 | 1 | 0 | 10 | 7.3 |
| Enterobacter spp. | 2 | 5 | 1 | 0 | 0 | 0 | 8 | 5.8 |
| Escherichia coli | 42 | 9 | 7 | 1 | 3 | 7 | 69 | 50.4 |
| Klebsiella spp. | 23 | 6 | 8 | 0 | 4 | 3 | 44 | 32.1 |
| Proteus spp. | 1 | 0 | 4 | 0 | 1 | 0 | 6 | 4.4 |
| Total | 70 (51.1 %) | 21 (15.3 %) | 26 (19.0 %) | 1 (0.7 %) | 9 (6.6 %) | 10 (7.3 %) | 137 | 100 |
Though only one instance of infection was observed from three CSF samples tested, it was separated due to the clinical significance of infection in the normally sterile cerebrospinal region
CSF cerebrospinal fluid, HVS high vaginal swab
aRefers to miscellaneous clinical sources (wound swabs, pus, aspirates, ear swabs)